GlucoTrack Historical Balance Sheet

GCTK Stock

USD 0.30 0.11 26.83%

Trend analysis of GlucoTrack balance sheet accounts such as Short and Long Term Debt Total of 246.7 K or Other Current Liab of 594.1 K provides information on GlucoTrack's total assets, liabilities, and equity, which is the actual value of GlucoTrack to its prevalent stockholders. By breaking down trends over time using GlucoTrack balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining GlucoTrack latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GlucoTrack is a good buy for the upcoming year.

GlucoTrack Inventory

0.0

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.

About GlucoTrack Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of GlucoTrack at a specified time, usually calculated after every quarter, six months, or one year. GlucoTrack Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of GlucoTrack and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which GlucoTrack currently owns. An asset can also be divided into two categories, current and non-current.

GlucoTrack Balance Sheet Chart

At this time, GlucoTrack's Other Stockholder Equity is quite stable compared to the past year. Net Tangible Assets is expected to rise to about 1.5 M this year, although the value of Total Current Liabilities will most likely fall to about 1.7 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of GlucoTrack assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in GlucoTrack books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from GlucoTrack's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into GlucoTrack current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.At this time, GlucoTrack's Other Stockholder Equity is quite stable compared to the past year. Net Tangible Assets is expected to rise to about 1.5 M this year, although the value of Total Current Liabilities will most likely fall to about 1.7 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	195K	196K	176.4K	246.7K
Total Assets	2.4M	4.9M	5.6M	3.8M

Short Long Term Debt Total Total Assets

GlucoTrack balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Other Liab	Net Tangible Assets	Other Assets	Property Plant Equipment	Long Term Debt
Common Stock Shares Outstanding		0.49	-0.15	-0.24	-0.06	0.59	0.18	-0.55	-0.72	0.02	0.53	-0.12	-0.53	0.53	-0.5	-0.2	0.66	-0.48	0.49	0.47	-0.35	-0.73	0.82	-0.76	-0.11	0.66
Total Assets	0.49		0.15	-0.22	-0.19	0.54	0.1	-0.97	-0.38	-0.22	0.98	-0.2	-0.48	0.98	-0.16	0.18	0.41	-0.18	1.0	0.28	0.03	-0.37	0.56	-0.48	-0.04	0.53
Short Long Term Debt Total	-0.15	0.15		-0.47	-0.51	-0.04	0.0	-0.16	0.43	-0.56	0.22	0.07	0.13	0.22	0.22	-0.27	-0.4	0.12	0.15	-0.04	0.55	0.35	-0.3	0.29	0.37	-0.28
Other Current Liab	-0.24	-0.22	-0.47		0.95	-0.42	0.21	0.31	-0.3	0.89	-0.32	0.3	0.36	-0.32	0.24	0.15	0.22	0.39	-0.24	0.22	-0.01	-0.18	0.06	0.06	-0.13	-0.02
Total Current Liabilities	-0.06	-0.19	-0.51	0.95		-0.4	0.44	0.29	-0.36	0.98	-0.32	0.47	0.42	-0.32	0.23	0.05	0.25	0.39	-0.22	0.35	-0.04	-0.24	0.14	0.0	0.0	0.01
Total Stockholder Equity	0.59	0.54	-0.04	-0.42	-0.4		-0.28	-0.66	-0.53	-0.38	0.64	-0.55	-0.79	0.64	-0.9	0.17	0.64	-0.92	0.56	0.35	-0.57	-0.67	0.74	-0.68	-0.3	0.67
Property Plant And Equipment Net	0.18	0.1	0.0	0.21	0.44	-0.28		0.04	0.05	0.49	-0.04	0.92	0.61	-0.04	0.3	-0.44	-0.18	0.36	0.04	0.63	0.23	0.09	-0.03	0.23	0.8	-0.27
Net Debt	-0.55	-0.97	-0.16	0.31	0.29	-0.66	0.04		0.43	0.32	-0.99	0.34	0.59	-0.99	0.3	-0.15	-0.47	0.33	-0.98	-0.28	0.04	0.45	-0.63	0.55	0.13	-0.57
Retained Earnings	-0.72	-0.38	0.43	-0.3	-0.36	-0.53	0.05	0.43		-0.39	-0.39	0.29	0.56	-0.39	0.53	-0.26	-0.96	0.44	-0.38	-0.47	0.42	0.97	-0.94	0.88	0.52	-0.81
Accounts Payable	0.02	-0.22	-0.56	0.89	0.98	-0.38	0.49	0.32	-0.39		-0.35	0.49	0.39	-0.35	0.19	0.03	0.28	0.35	-0.25	0.37	-0.14	-0.27	0.18	-0.04	0.02	0.03
Cash	0.53	0.98	0.22	-0.32	-0.32	0.64	-0.04	-0.99	-0.39	-0.35		-0.33	-0.57	1.0	-0.27	0.13	0.43	-0.32	0.98	0.27	0.0	-0.41	0.59	-0.52	-0.1	0.56
Non Current Assets Total	-0.12	-0.2	0.07	0.3	0.47	-0.55	0.92	0.34	0.29	0.49	-0.33		0.86	-0.33	0.48	-0.52	-0.43	0.54	-0.25	0.46	0.42	0.32	-0.33	0.52	0.83	-0.55
Non Currrent Assets Other	-0.53	-0.48	0.13	0.36	0.42	-0.79	0.61	0.59	0.56	0.39	-0.57	0.86		-0.57	0.65	-0.48	-0.69	0.7	-0.52	0.1	0.57	0.59	-0.66	0.81	0.67	-0.8
Cash And Short Term Investments	0.53	0.98	0.22	-0.32	-0.32	0.64	-0.04	-0.99	-0.39	-0.35	1.0	-0.33	-0.57		-0.27	0.13	0.43	-0.32	0.98	0.27	0.0	-0.41	0.59	-0.52	-0.1	0.56
Non Current Liabilities Total	-0.5	-0.16	0.22	0.24	0.23	-0.9	0.3	0.3	0.53	0.19	-0.27	0.48	0.65	-0.27		-0.09	-0.62	0.99	-0.18	-0.37	0.73	0.68	-0.66	0.6	0.33	-0.56
Other Current Assets	-0.2	0.18	-0.27	0.15	0.05	0.17	-0.44	-0.15	-0.26	0.03	0.13	-0.52	-0.48	0.13	-0.09		0.42	-0.1	0.19	-0.34	-0.25	-0.21	0.17	-0.41	-0.62	0.51
Other Stockholder Equity	0.66	0.41	-0.4	0.22	0.25	0.64	-0.18	-0.47	-0.96	0.28	0.43	-0.43	-0.69	0.43	-0.62	0.42		-0.55	0.42	0.4	-0.49	-0.96	0.94	-0.92	-0.59	0.9
Total Liab	-0.48	-0.18	0.12	0.39	0.39	-0.92	0.36	0.33	0.44	0.35	-0.32	0.54	0.7	-0.32	0.99	-0.1	-0.55		-0.21	-0.28	0.68	0.61	-0.6	0.57	0.32	-0.54
Total Current Assets	0.49	1.0	0.15	-0.24	-0.22	0.56	0.04	-0.98	-0.38	-0.25	0.98	-0.25	-0.52	0.98	-0.18	0.19	0.42	-0.21		0.25	0.0	-0.38	0.56	-0.5	-0.08	0.54
Common Stock	0.47	0.28	-0.04	0.22	0.35	0.35	0.63	-0.28	-0.47	0.37	0.27	0.46	0.1	0.27	-0.37	-0.34	0.4	-0.28	0.25		-0.05	-0.55	0.56	-0.22	0.42	0.17
Short Term Debt	-0.35	0.03	0.55	-0.01	-0.04	-0.57	0.23	0.04	0.42	-0.14	0.0	0.42	0.57	0.0	0.73	-0.25	-0.49	0.68	0.0	-0.05		0.45	-0.46	0.49	0.39	-0.48
Other Liab	-0.73	-0.37	0.35	-0.18	-0.24	-0.67	0.09	0.45	0.97	-0.27	-0.41	0.32	0.59	-0.41	0.68	-0.21	-0.96	0.61	-0.38	-0.55	0.45		-0.97	0.87	0.47	-0.81
Net Tangible Assets	0.82	0.56	-0.3	0.06	0.14	0.74	-0.03	-0.63	-0.94	0.18	0.59	-0.33	-0.66	0.59	-0.66	0.17	0.94	-0.6	0.56	0.56	-0.46	-0.97		-0.89	-0.4	0.84
Other Assets	-0.76	-0.48	0.29	0.06	0.0	-0.68	0.23	0.55	0.88	-0.04	-0.52	0.52	0.81	-0.52	0.6	-0.41	-0.92	0.57	-0.5	-0.22	0.49	0.87	-0.89		0.57	-0.95
Property Plant Equipment	-0.11	-0.04	0.37	-0.13	0.0	-0.3	0.8	0.13	0.52	0.02	-0.1	0.83	0.67	-0.1	0.33	-0.62	-0.59	0.32	-0.08	0.42	0.39	0.47	-0.4	0.57		-0.59
Long Term Debt	0.66	0.53	-0.28	-0.02	0.01	0.67	-0.27	-0.57	-0.81	0.03	0.56	-0.55	-0.8	0.56	-0.56	0.51	0.9	-0.54	0.54	0.17	-0.48	-0.81	0.84	-0.95	-0.59

Click cells to compare fundamentals

GlucoTrack Account Relationship Matchups

GlucoTrack balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	15.1M	15.5M	15.5M	4.2M	4.8M	4.9M
Total Assets	10.6M	6.3M	2.4M	4.9M	5.6M	3.8M
Short Long Term Debt Total	363K	250K	195K	196K	176.4K	246.7K
Other Current Liab	392K	229K	341K	673K	774.0K	594.1K
Total Current Liabilities	1.3M	883K	1.0M	1.5M	1.7M	1.7M
Total Stockholder Equity	9.0M	5.2M	1.2M	3.2M	3.7M	3.9M
Property Plant And Equipment Net	315K	109K	40K	27K	31.1K	29.5K
Net Debt	(9.5M)	(5.8M)	(2.1M)	(4.3M)	(3.9M)	(3.7M)
Retained Earnings	(93.4M)	(97.5M)	(101.9M)	(109.9M)	(98.9M)	(93.9M)
Accounts Payable	869K	631K	672K	839K	964.9K	1.0M
Cash	9.8M	6.1M	2.3M	4.5M	5.2M	2.9M
Non Current Assets Total	377K	160K	59K	37K	33.3K	31.6K
Non Currrent Assets Other	62K	51K	4K	10K	9K	8.6K
Cash And Short Term Investments	9.8M	6.1M	2.3M	4.5M	5.2M	2.9M
Liabilities And Stockholders Equity	10.6M	6.3M	2.4M	4.9M	5.6M	3.8M
Non Current Liabilities Total	279K	227K	195K	196K	176.4K	167.6K
Other Current Assets	56K	43K	67K	376K	432.4K	454.0K
Other Stockholder Equity	102.4M	102.6M	103.1M	113.0M	129.9M	136.4M
Total Liab	1.6M	1.1M	1.2M	1.7M	1.5M	1.5M
Total Current Assets	10.2M	6.1M	2.4M	4.9M	5.6M	3.4M
Accumulated Other Comprehensive Income	15K	(6K)	17K	64K	73.6K	67.1K
Common Stock	162.8K	201K	15K	20K	23K	21.9K
Net Tangible Assets	(1.4M)	9.0M	5.2M	1.2M	1.4M	1.5M
Other Assets	62K	0.0	19K	1.0	0.9	0.86
Property Plant Equipment	321K	315K	109K	40K	36K	34.2K
Long Term Debt	197K	210K	195K	196K	225.4K	212.0K
Net Invested Capital	9.2M	5.4M	1.4M	3.4M	3.9M	2.8M
Capital Stock	162.8K	201K	15K	20K	18K	17.1K
Net Working Capital	8.9M	5.2M	1.4M	3.4M	3.9M	2.6M
Property Plant And Equipment Gross	940K	529K	294K	27K	24.3K	23.1K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether GlucoTrack is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlucoTrack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glucotrack Stock. Highlighted below are key reports to facilitate an investment decision about Glucotrack Stock:

How To Invest In GlucoTrack

Details

Is GlucoTrack Stock a good investment?

Details

What is GlucoTrack's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(58.20)

Return On Assets

(2.04)

Return On Equity

(19.43)

The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GlucoTrack Historical Balance Sheet

GlucoTrack Inventory

0.0

About GlucoTrack Balance Sheet Analysis

GlucoTrack Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

GlucoTrack balance sheet Correlations

GlucoTrack Account Relationship Matchups

High Positive Relationship

High Negative Relationship

GlucoTrack balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Non Current Liabilities Total
Cash	+ 0.98	Total Assets
Cash And Short Term Investments	+ 0.98	Total Assets
Accounts Payable	+ 0.98	Total Current Liabilities

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Total Current Assets	- 0.98	Net Debt
Net Tangible Assets	- 0.97	Other Liab
Net Debt	- 0.97	Total Assets
Other Liab	- 0.96	Other Stockholder Equity